Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Wait times to see a cardiologist keep increasing | FDA approves Abbott's TMVR device | PPMI after mitral valve surgery

News You Need to Know Today
Wait times to see a cardiologist keep increasing | FDA approves Abbott's TMVR device | PPMI after mitral valve surgery
Wednesday, May 28, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

The average wait time to see a cardiologist is now more than a month

To be exact, the average weight time for a cardiologist appointment in U.S. cities is 32.7 days. This is a 23% increase compared to 2022 and a 74% increase compared to 2004.

READ MORE >
Patients in waiting room.
Share on Twitter Share on Facebook Share on Linkedin

The average wait time to see a cardiologist is now more than a month

Share on Twitter Share on Facebook Share on Linkedin
Patients in waiting room.
To be exact, the average weight time for a cardiologist appointment in U.S. cities is 32.7 days. This is a 23% increase compared to 2022 and a 74% increase compared to 2004.
READ MORE >

FDA approves self-expanding Tendyne TMVR device from Abbott

The self-expanding valve, which gained CE mark approval back in 2020, is available in multiple sizes and can be fully retrieved and repositioned as it is implanted.

READ MORE >
Abbott's Tendyne TMVR device | Mitral valve replacement
Share on Twitter Share on Facebook Share on Linkedin

FDA approves self-expanding Tendyne TMVR device from Abbott

Share on Twitter Share on Facebook Share on Linkedin
Abbott's Tendyne TMVR device | Mitral valve replacement
The self-expanding valve, which gained CE mark approval back in 2020, is available in multiple sizes and can be fully retrieved and repositioned as it is implanted.
READ MORE >

Permanent pacemaker implantation after mitral valve surgery: Exploring the impact on long-term survival

PPMI after aortic valve surgery is known to increase certain risks for patients, but its impact after mitral valve procedures is unclear. A team of researchers aimed to learn more, tracking data from more than 4,500 patients.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Permanent pacemaker implantation after mitral valve surgery: Exploring the impact on long-term survival

Share on Twitter Share on Facebook Share on Linkedin
PPMI after aortic valve surgery is known to increase certain risks for patients, but its impact after mitral valve procedures is unclear. A team of researchers aimed to learn more, tracking data from more than 4,500 patients.
READ MORE >

Featured Articles

SCAI wants lead-free cath labs and a better work-life balance for cardiologists

"The lead protection we wear is causing a lot of damage," SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, explained in an interview.

READ MORE >
Video interview with Hari Naidu SCAI president on the need for policy for increased radiation protection in the cath lab.
Share on Twitter Share on Facebook Share on Linkedin

SCAI wants lead-free cath labs and a better work-life balance for cardiologists

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Hari Naidu SCAI president on the need for policy for increased radiation protection in the cath lab.
"The lead protection we wear is causing a lot of damage," SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, explained in an interview.
READ MORE >

Cardiologist shares positive first-in-human data on TriCares TTVR device

The new Topaz TTVR system was associated with the consistent elimination of tricuspid regurgitation. In addition, none of the first 20 patients treated with the device required a permanent pacemaker as a result of the procedure.

READ MORE >
The Topaz transcatheter tricuspid valve replacement (TTVR) system. TriCares GmbH, a global medtech company with offices in France, Germany, the United States and Brazil, has announced the presentation of new first-in-human data on its self-expanding Topaz transcatheter tricuspid valve replacement (TTVR) system. Julien Dreyfus, MD, PhD, a cardiologist with Centre Cardiologique du Nord in France who specializes in tricuspid treatments, presented the findings at EuroPCR in Paris.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist shares positive first-in-human data on TriCares TTVR device

Share on Twitter Share on Facebook Share on Linkedin
The Topaz transcatheter tricuspid valve replacement (TTVR) system. TriCares GmbH, a global medtech company with offices in France, Germany, the United States and Brazil, has announced the presentation of new first-in-human data on its self-expanding Topaz transcatheter tricuspid valve replacement (TTVR) system. Julien Dreyfus, MD, PhD, a cardiologist with Centre Cardiologique du Nord in France who specializes in tricuspid treatments, presented the findings at EuroPCR in Paris.
The new Topaz TTVR system was associated with the consistent elimination of tricuspid regurgitation. In addition, none of the first 20 patients treated with the device required a permanent pacemaker as a result of the procedure.
READ MORE >

Medtronic drug-coated balloon gains multiple new approvals

The Prevail DCB has been cleared to use in dozens of countries around the globe, but it has not yet been approved by the FDA.

READ MORE >
Prevail DCB Medtronic. Medtronic’s Prevail drug-coated balloon (DCB) has received CE mark approval for several new indications related to the treatment of coronary artery disease (CAD). The paclitaxel-coated device, designed to inflate within the patient’s artery during percutaneous coronary intervention (PCI) procedures, is now approved across the EU to treat CAD patients with multivessel disease, acute coronary syndrome and diabetes.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic drug-coated balloon gains multiple new approvals

Share on Twitter Share on Facebook Share on Linkedin
Prevail DCB Medtronic. Medtronic’s Prevail drug-coated balloon (DCB) has received CE mark approval for several new indications related to the treatment of coronary artery disease (CAD). The paclitaxel-coated device, designed to inflate within the patient’s artery during percutaneous coronary intervention (PCI) procedures, is now approved across the EU to treat CAD patients with multivessel disease, acute coronary syndrome and diabetes.
The Prevail DCB has been cleared to use in dozens of countries around the globe, but it has not yet been approved by the FDA.
READ MORE >

Meril TAVR valves linked to 1-year outcomes similar to industry-leading devices from Medtronic, Edwards

Indian medtech company Meril Life Sciences has been manufacturing its Myval TAVR valves for years, but FDA approval has remained out of reach. These latest data represent a one-year update of the multicenter LANDMARK clinical trial.

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

Meril TAVR valves linked to 1-year outcomes similar to industry-leading devices from Medtronic, Edwards

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
Indian medtech company Meril Life Sciences has been manufacturing its Myval TAVR valves for years, but FDA approval has remained out of reach. These latest data represent a one-year update of the multicenter LANDMARK clinical trial.
READ MORE >

In Case You Missed It

FDA approves popular ultrasound enhancing agent for pediatric patients

Unlike other UEA options, GE HealthCare's Optison does not contain polyethylene glycol. The FDA approved its use for adult patients back in 1997.

READ MORE >
GE HealthCare Optison ultrasound enhancing agent used to enhance otherwise suboptimal echocardiograms and better show the borders of the chambers of the heart.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves popular ultrasound enhancing agent for pediatric patients

Share on Twitter Share on Facebook Share on Linkedin
GE HealthCare Optison ultrasound enhancing agent used to enhance otherwise suboptimal echocardiograms and better show the borders of the chambers of the heart.
Unlike other UEA options, GE HealthCare's Optison does not contain polyethylene glycol. The FDA approved its use for adult patients back in 1997.
READ MORE >

Cardiologist highlights safety, effectiveness of Boston Scientific TAVR valve

Andreas Ruck, MD, discussed new registry data on Boston Scientific’s Acurate neo2 TAVR valve, comparing it to popular devices from Edwards Lifesciences and Medtronic.

READ MORE >
Video interview with Andreas Ruck, MD, explaining a SWEDHEART registry comparison of Acurate Neo2 to Sapien and Evolut TAVR valves.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist highlights safety, effectiveness of Boston Scientific TAVR valve

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Andreas Ruck, MD, explaining a SWEDHEART registry comparison of Acurate Neo2 to Sapien and Evolut TAVR valves.
Andreas Ruck, MD, discussed new registry data on Boston Scientific’s Acurate neo2 TAVR valve, comparing it to popular devices from Edwards Lifesciences and Medtronic.
READ MORE >

FDA gives AI-powered blood test for obstructive CAD breakthrough device designation

The FDA clearly sees significant potential in a new multi-protein blood test from Prevencio. The company's goal is to gain full approval and get the test in the hands of emergency departments all over the United States.

READ MORE >
blood test research laboratory
Share on Twitter Share on Facebook Share on Linkedin

FDA gives AI-powered blood test for obstructive CAD breakthrough device designation

Share on Twitter Share on Facebook Share on Linkedin
blood test research laboratory
The FDA clearly sees significant potential in a new multi-protein blood test from Prevencio. The company's goal is to gain full approval and get the test in the hands of emergency departments all over the United States.
READ MORE >

In Other News

FDA issues Class I alert on emergency use esophagogastric tubes

A serious issue with esophagogastric balloon tamponade tubes manufactured by BD could cause the devices to break, potentially delaying care for bleeding patients. Clinicians are advised to review and follow updated use instructions.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA issues Class I alert on emergency use esophagogastric tubes

Share on Twitter Share on Facebook Share on Linkedin
A serious issue with esophagogastric balloon tamponade tubes manufactured by BD could cause the devices to break, potentially delaying care for bleeding patients. Clinicians are advised to review and follow updated use instructions.
READ MORE >

Predictive model uses 6 ultrasound features to differentiate between benign and malignant thyroid nodules

Once the model is further validated, it could help guide providers in determining how to manage thyroid nodules. 

READ MORE >
Predictive model helps identify malignancy in thyroid nodules.
Share on Twitter Share on Facebook Share on Linkedin

Predictive model uses 6 ultrasound features to differentiate between benign and malignant thyroid nodules

Share on Twitter Share on Facebook Share on Linkedin
Predictive model helps identify malignancy in thyroid nodules.
Once the model is further validated, it could help guide providers in determining how to manage thyroid nodules. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Star Trek star's family awarded $13M | AI for cardiac amyloidosis | TAVR concerns | New CKM syndrome guidelines
A brand new payment model | Cardiologist compensation keeps rising | Major medtech player invests $1.5B in TAVR tech
Death after TAVR: New data support a change | Rural hospital in spotlight for wrong reason | Heart changes linked to cancer risk
Physicians push back after government report | Device recalled | A lesson for PAD patients | AI for long-term stroke risk
The pros & cons of direct-to-patient drug programs | Why PAD patients should listen to their doctors
Coffee linked to major heart risk | Ablations in ASCs | Catheters recalled | A closer look at PFA | GLP-1 drugs & AFib
New guidelines for cardiovascular-kidney-metabolic syndrome and M-TEER | HF cell therapy company raises $4.4 million

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup